Envoy Medical draws $5M from GAT Funding note, issues warrant for 500k shares

Envoy Medical, Inc.

Drew $5M under promissory note from GAT Funding (entity controlled by board member Glen Taylor); total principal now $10M.
Issued warrant to purchase 500k shares of Class A common stock at $2.20/share as commitment fee.
Warrant expires Dec 11, 2026; exercise price equals closing price on draw date.
Note originally issued Aug 27, 2024 for up to $10M; this draw reaches maximum principal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.